Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asfar S Azmi

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Gastroenterology|October 24, 2012
Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in miceAsfar S Azmi, Amro Aboukameel, Bin Bao, et al.
Frontiers in Digital Health|April 17, 2026
Evaluating the quality of online patient education materials for gastric adenocarcinomaTrisha Ray, Taylor Barrow, Lauren Hamel, et al.
Small Gtpases|June 23, 2017
Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferationRamzi M Mohammad, Yiwei Li, Irfana Muqbil, et al.
Cancers|July 2, 2021
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to BedsideMd Hafiz Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, et al.
Cancer Letters|April 6, 2011
Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cellsBin Bao, Zhiwei Wang, Shadan Ali, et al.
Journal of Cellular Biochemistry|April 20, 2011
Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cellsBin Bao, Zhiwei Wang, Shadan Ali, et al.
Cancer Letters|April 3, 2018
Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells"Bin Bao, Zhiwei Wang, Shadan Ali, et al.
Molecular Cancer|December 5, 2009
An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animalsRamzi M Mohammad, Jack Wu, Asfar S Azmi, et al.
Pharmaceutical Research|April 28, 2010
Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancerSanjeev Banerjee, Asfar S Azmi, Subhash Padhye, et al.
American Journal of Translational Research|September 10, 2011
Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanismAsfar S Azmi, Shadan Ali, Sanjeev Banerjee, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Gastroenterology|October 24, 2012
Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in miceAsfar S Azmi, Amro Aboukameel, Bin Bao, et al.
Frontiers in Digital Health|April 17, 2026
Evaluating the quality of online patient education materials for gastric adenocarcinomaTrisha Ray, Taylor Barrow, Lauren Hamel, et al.
Small Gtpases|June 23, 2017
Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferationRamzi M Mohammad, Yiwei Li, Irfana Muqbil, et al.
Cancers|July 2, 2021
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to BedsideMd Hafiz Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, et al.
Cancer Letters|April 6, 2011
Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cellsBin Bao, Zhiwei Wang, Shadan Ali, et al.
Journal of Cellular Biochemistry|April 20, 2011
Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cellsBin Bao, Zhiwei Wang, Shadan Ali, et al.
Cancer Letters|April 3, 2018
Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells"Bin Bao, Zhiwei Wang, Shadan Ali, et al.
Molecular Cancer|December 5, 2009
An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animalsRamzi M Mohammad, Jack Wu, Asfar S Azmi, et al.
Pharmaceutical Research|April 28, 2010
Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancerSanjeev Banerjee, Asfar S Azmi, Subhash Padhye, et al.
American Journal of Translational Research|September 10, 2011
Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanismAsfar S Azmi, Shadan Ali, Sanjeev Banerjee, et al.
Pageof 16